Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Rivaroxaban and dabigatran are new oral anticoagulants that specifically inhibit factor Xa and thrombin, respectively. Clinical studies on the prevention and treatment of venous and arterial thromboembolism show promising results. A major disadvantage of these anticoagulants is the absence of an ant...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Circulation (New York, N.Y.) Ročník 124; číslo 14; s. 1573
Hlavní autoři: Eerenberg, Elise S, Kamphuisen, Pieter W, Sijpkens, Meertien K, Meijers, Joost C, Buller, Harry R, Levi, Marcel
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 04.10.2011
Témata:
ISSN:1524-4539, 1524-4539
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Rivaroxaban and dabigatran are new oral anticoagulants that specifically inhibit factor Xa and thrombin, respectively. Clinical studies on the prevention and treatment of venous and arterial thromboembolism show promising results. A major disadvantage of these anticoagulants is the absence of an antidote in case of serious bleeding or when an emergency intervention needs immediate correction of coagulation. This study evaluated the potential of prothrombin complex concentrate (PCC) to reverse the anticoagulant effect of these drugs. In a randomized, double-blind, placebo-controlled study, 12 healthy male volunteers received rivaroxaban 20 mg twice daily (n=6) or dabigatran 150 mg twice daily (n=6) for 2½ days, followed by either a single bolus of 50 IU/kg PCC (Cofact) or a similar volume of saline. After a washout period, this procedure was repeated with the other anticoagulant treatment. Rivaroxaban induced a significant prolongation of the prothrombin time (15.8±1.3 versus 12.3±0.7 seconds at baseline; P<0.001) that was immediately and completely reversed by PCC (12.8±1.0; P<0.001). The endogenous thrombin potential was inhibited by rivaroxaban (51±22%; baseline, 92±22%; P=0.002) and normalized with PCC (114±26%; P<0.001), whereas saline had no effect. Dabigatran increased the activated partial thromboplastin time, ecarin clotting time (ECT), and thrombin time. Administration of PCC did not restore these coagulation tests. Prothrombin complex concentrate immediately and completely reverses the anticoagulant effect of rivaroxaban in healthy subjects but has no influence on the anticoagulant action of dabigatran at the PCC dose used in this study. Clinical Trial Registration- URL: http://www.trialregister.nl. Unique identifier: NTR2272.
AbstractList Rivaroxaban and dabigatran are new oral anticoagulants that specifically inhibit factor Xa and thrombin, respectively. Clinical studies on the prevention and treatment of venous and arterial thromboembolism show promising results. A major disadvantage of these anticoagulants is the absence of an antidote in case of serious bleeding or when an emergency intervention needs immediate correction of coagulation. This study evaluated the potential of prothrombin complex concentrate (PCC) to reverse the anticoagulant effect of these drugs. In a randomized, double-blind, placebo-controlled study, 12 healthy male volunteers received rivaroxaban 20 mg twice daily (n=6) or dabigatran 150 mg twice daily (n=6) for 2½ days, followed by either a single bolus of 50 IU/kg PCC (Cofact) or a similar volume of saline. After a washout period, this procedure was repeated with the other anticoagulant treatment. Rivaroxaban induced a significant prolongation of the prothrombin time (15.8±1.3 versus 12.3±0.7 seconds at baseline; P<0.001) that was immediately and completely reversed by PCC (12.8±1.0; P<0.001). The endogenous thrombin potential was inhibited by rivaroxaban (51±22%; baseline, 92±22%; P=0.002) and normalized with PCC (114±26%; P<0.001), whereas saline had no effect. Dabigatran increased the activated partial thromboplastin time, ecarin clotting time (ECT), and thrombin time. Administration of PCC did not restore these coagulation tests. Prothrombin complex concentrate immediately and completely reverses the anticoagulant effect of rivaroxaban in healthy subjects but has no influence on the anticoagulant action of dabigatran at the PCC dose used in this study. Clinical Trial Registration- URL: http://www.trialregister.nl. Unique identifier: NTR2272.
Rivaroxaban and dabigatran are new oral anticoagulants that specifically inhibit factor Xa and thrombin, respectively. Clinical studies on the prevention and treatment of venous and arterial thromboembolism show promising results. A major disadvantage of these anticoagulants is the absence of an antidote in case of serious bleeding or when an emergency intervention needs immediate correction of coagulation. This study evaluated the potential of prothrombin complex concentrate (PCC) to reverse the anticoagulant effect of these drugs.BACKGROUNDRivaroxaban and dabigatran are new oral anticoagulants that specifically inhibit factor Xa and thrombin, respectively. Clinical studies on the prevention and treatment of venous and arterial thromboembolism show promising results. A major disadvantage of these anticoagulants is the absence of an antidote in case of serious bleeding or when an emergency intervention needs immediate correction of coagulation. This study evaluated the potential of prothrombin complex concentrate (PCC) to reverse the anticoagulant effect of these drugs.In a randomized, double-blind, placebo-controlled study, 12 healthy male volunteers received rivaroxaban 20 mg twice daily (n=6) or dabigatran 150 mg twice daily (n=6) for 2½ days, followed by either a single bolus of 50 IU/kg PCC (Cofact) or a similar volume of saline. After a washout period, this procedure was repeated with the other anticoagulant treatment. Rivaroxaban induced a significant prolongation of the prothrombin time (15.8±1.3 versus 12.3±0.7 seconds at baseline; P<0.001) that was immediately and completely reversed by PCC (12.8±1.0; P<0.001). The endogenous thrombin potential was inhibited by rivaroxaban (51±22%; baseline, 92±22%; P=0.002) and normalized with PCC (114±26%; P<0.001), whereas saline had no effect. Dabigatran increased the activated partial thromboplastin time, ecarin clotting time (ECT), and thrombin time. Administration of PCC did not restore these coagulation tests.METHODS AND RESULTSIn a randomized, double-blind, placebo-controlled study, 12 healthy male volunteers received rivaroxaban 20 mg twice daily (n=6) or dabigatran 150 mg twice daily (n=6) for 2½ days, followed by either a single bolus of 50 IU/kg PCC (Cofact) or a similar volume of saline. After a washout period, this procedure was repeated with the other anticoagulant treatment. Rivaroxaban induced a significant prolongation of the prothrombin time (15.8±1.3 versus 12.3±0.7 seconds at baseline; P<0.001) that was immediately and completely reversed by PCC (12.8±1.0; P<0.001). The endogenous thrombin potential was inhibited by rivaroxaban (51±22%; baseline, 92±22%; P=0.002) and normalized with PCC (114±26%; P<0.001), whereas saline had no effect. Dabigatran increased the activated partial thromboplastin time, ecarin clotting time (ECT), and thrombin time. Administration of PCC did not restore these coagulation tests.Prothrombin complex concentrate immediately and completely reverses the anticoagulant effect of rivaroxaban in healthy subjects but has no influence on the anticoagulant action of dabigatran at the PCC dose used in this study. Clinical Trial Registration- URL: http://www.trialregister.nl. Unique identifier: NTR2272.CONCLUSIONProthrombin complex concentrate immediately and completely reverses the anticoagulant effect of rivaroxaban in healthy subjects but has no influence on the anticoagulant action of dabigatran at the PCC dose used in this study. Clinical Trial Registration- URL: http://www.trialregister.nl. Unique identifier: NTR2272.
Author Levi, Marcel
Eerenberg, Elise S
Meijers, Joost C
Kamphuisen, Pieter W
Sijpkens, Meertien K
Buller, Harry R
Author_xml – sequence: 1
  givenname: Elise S
  surname: Eerenberg
  fullname: Eerenberg, Elise S
  email: e.s.eerenberg@amc.uva.nl
  organization: Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands. e.s.eerenberg@amc.uva.nl
– sequence: 2
  givenname: Pieter W
  surname: Kamphuisen
  fullname: Kamphuisen, Pieter W
– sequence: 3
  givenname: Meertien K
  surname: Sijpkens
  fullname: Sijpkens, Meertien K
– sequence: 4
  givenname: Joost C
  surname: Meijers
  fullname: Meijers, Joost C
– sequence: 5
  givenname: Harry R
  surname: Buller
  fullname: Buller, Harry R
– sequence: 6
  givenname: Marcel
  surname: Levi
  fullname: Levi, Marcel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21900088$$D View this record in MEDLINE/PubMed
BookMark eNpNkFtLAzEQhYNUtK3-BYlPvria7CW78a0UL4ViQfS55DJrV7KbNcmW1l_hTzaigk8z5_BxhjMTNOpsBwidU3JFKaPX88XT_GU5e16sHmcPs-jRK5JyQssDNKZFmid5kfHRv_0YTbx_I4SwrCyO0HFKeRRVNUafT7AF54XBtsau2Qpnd0KKDotOYy1k8yqCi1Luce9s2DjbyqbDyra9gV2cnYIuEgFusMCR1LZtPkBf4t4IBdImEQnOGvPtKWe9t_Eg9mHQexyTNiBM2OyxH-QbqOBP0GEtjIfT3zlFL3e3z_OHZLm6X8xny0RlOQsJV3UODGqRal0QpVhVaZ1BrgnXZV1Q-V2QypTJQlZpXlJKOIeCcEYYZDVLp-jiJzfWeh_Ah3XbeAXGiA7s4NcVZxnPaJVH8uyXHGQLet27phVuv_57YvoFnrR76Q
CitedBy_id crossref_primary_10_1177_0091270011432169
crossref_primary_10_1016_j_jacc_2017_09_1085
crossref_primary_10_1016_j_lpm_2012_03_002
crossref_primary_10_1155_2012_867121
crossref_primary_10_2217_fca_15_38
crossref_primary_10_1016_j_wneu_2012_10_023
crossref_primary_10_1160_TH12_05_0319
crossref_primary_10_1016_j_amjcard_2013_03_054
crossref_primary_10_1093_bja_aes502
crossref_primary_10_1007_s11936_013_0230_0
crossref_primary_10_3171_2014_8_paradigm
crossref_primary_10_1007_s11239_013_0885_0
crossref_primary_10_1186_s13256_018_1660_9
crossref_primary_10_1160_TH12_12_0907
crossref_primary_10_1007_s11239_018_1645_y
crossref_primary_10_1111_jth_12164
crossref_primary_10_1016_j_ijcard_2014_04_151
crossref_primary_10_1016_j_annfar_2014_07_003
crossref_primary_10_1182_blood_2014_06_578948
crossref_primary_10_1016_j_nec_2018_06_005
crossref_primary_10_2217_cpr_12_63
crossref_primary_10_1016_j_jacc_2012_09_062
crossref_primary_10_2217_cpr_12_60
crossref_primary_10_1007_s12028_015_0167_0
crossref_primary_10_1007_s11239_015_1297_0
crossref_primary_10_1097_TA_0000000000002979
crossref_primary_10_1016_j_thromres_2015_05_024
crossref_primary_10_1007_s00508_014_0509_5
crossref_primary_10_1634_theoncologist_2013_0239
crossref_primary_10_1038_nm_4149
crossref_primary_10_1007_s00398_014_1120_9
crossref_primary_10_3390_ph5040384
crossref_primary_10_1007_s40138_015_0079_5
crossref_primary_10_1177_1747493016660100
crossref_primary_10_3389_fneur_2017_00080
crossref_primary_10_1007_s40292_016_0150_7
crossref_primary_10_1016_j_bjane_2021_03_007
crossref_primary_10_1016_j_jchirv_2013_11_005
crossref_primary_10_1016_S0049_3848_12_70035_X
crossref_primary_10_1155_2013_973710
crossref_primary_10_1016_j_ijcard_2014_11_101
crossref_primary_10_1111_jth_12140
crossref_primary_10_1097_MCP_0b013e3283560729
crossref_primary_10_1213_ANE_0000000000001188
crossref_primary_10_1002_rth2_12015
crossref_primary_10_1016_j_emc_2014_04_010
crossref_primary_10_1016_j_jacc_2013_11_039
crossref_primary_10_1093_europace_euab065
crossref_primary_10_1016_j_jacc_2016_02_082
crossref_primary_10_1111_jcpt_12207
crossref_primary_10_1016_j_amjcard_2013_03_046
crossref_primary_10_1213_ANE_0b013e318273f4ae
crossref_primary_10_1097_TA_0b013e318265cf9e
crossref_primary_10_1517_14656566_2013_780029
crossref_primary_10_3928_01477447_20121101_17
crossref_primary_10_1016_j_thorsurg_2015_04_005
crossref_primary_10_1097_MCC_0000000000000181
crossref_primary_10_1186_s12959_017_0158_9
crossref_primary_10_1007_s40140_020_00382_w
crossref_primary_10_1007_s12028_012_9757_2
crossref_primary_10_1016_j_redare_2016_05_002
crossref_primary_10_1007_s11239_017_1555_4
crossref_primary_10_1053_j_jvca_2016_01_005
crossref_primary_10_1007_s00063_013_0257_8
crossref_primary_10_1345_aph_1R155
crossref_primary_10_1586_14779072_2013_824181
crossref_primary_10_1007_s11239_015_1288_1
crossref_primary_10_1016_j_suc_2014_09_012
crossref_primary_10_1016_j_curtheres_2014_06_002
crossref_primary_10_1161_CIRCOUTCOMES_112_966572
crossref_primary_10_1097_ALN_0000000000001631
crossref_primary_10_1097_ALN_0000000000000541
crossref_primary_10_1111_bjh_13431
crossref_primary_10_1111_bjh_12106
crossref_primary_10_1002_jppr_1020
crossref_primary_10_1016_j_jacc_2016_01_072
crossref_primary_10_1002_rth2_12035
crossref_primary_10_1517_13543784_2012_696611
crossref_primary_10_1007_s00402_021_04152_z
crossref_primary_10_1161_STR_0b013e318266722a
crossref_primary_10_1186_s13054_016_1265_x
crossref_primary_10_1007_s40256_015_0123_6
crossref_primary_10_1097_PEC_0000000000002431
crossref_primary_10_1186_1477_9560_12_8
crossref_primary_10_4997_JRCPE_2012_112
crossref_primary_10_1111_bjh_12107
crossref_primary_10_1016_j_clinthera_2012_12_005
crossref_primary_10_1016_j_thromres_2020_09_028
crossref_primary_10_1093_rheumatology_kev445
crossref_primary_10_1097_MBC_0000000000000291
crossref_primary_10_1002_phar_2525
crossref_primary_10_1007_s12028_015_0158_1
crossref_primary_10_1016_j_tru_2025_100215
crossref_primary_10_1179_2045772314Y_0000000230
crossref_primary_10_1016_j_ccc_2012_04_002
crossref_primary_10_1097_ALN_0000000000000520
crossref_primary_10_1016_j_ccc_2012_04_005
crossref_primary_10_1097_ACO_0b013e32835b82df
crossref_primary_10_1161_CIRCULATIONAHA_116_021831
crossref_primary_10_1155_2014_548272
crossref_primary_10_3810_hp_2013_02_1008
crossref_primary_10_1007_s40262_013_0034_0
crossref_primary_10_3810_hp_2013_02_1006
crossref_primary_10_1007_s40265_015_0405_y
crossref_primary_10_1177_0885066619882909
crossref_primary_10_1160_TH11_10_0718
crossref_primary_10_1111_jth_12599
crossref_primary_10_1016_j_bios_2017_04_015
crossref_primary_10_1586_14779072_2013_839214
crossref_primary_10_1002_clc_22037
crossref_primary_10_1186_cc13717
crossref_primary_10_1161_STR_0000000000000407
crossref_primary_10_1185_03007995_2014_975786
crossref_primary_10_1160_TH12_05_0330
crossref_primary_10_1016_j_giec_2018_02_007
crossref_primary_10_1016_j_jstrokecerebrovasdis_2012_01_011
crossref_primary_10_1038_nrneurol_2012_77
crossref_primary_10_1177_1753944718801554
crossref_primary_10_1016_j_autrev_2014_01_053
crossref_primary_10_1016_j_suc_2012_08_011
crossref_primary_10_1016_j_ncl_2013_03_001
crossref_primary_10_1097_MAJ_0b013e31826c5a56
crossref_primary_10_1007_s11883_012_0258_8
crossref_primary_10_1016_j_jemermed_2016_11_011
crossref_primary_10_1056_NEJMc1112500
crossref_primary_10_1007_s11239_023_02820_y
crossref_primary_10_1345_aph_1Q705
crossref_primary_10_1371_journal_pone_0078696
crossref_primary_10_1007_s12471_013_0473_0
crossref_primary_10_1186_cc12685
crossref_primary_10_1177_2516608518821745
crossref_primary_10_1007_s12024_016_9745_5
crossref_primary_10_1111_coa_12148
crossref_primary_10_1586_erc_12_172
crossref_primary_10_1016_S0140_6736_15_60245_8
crossref_primary_10_1007_s11910_014_0471_7
crossref_primary_10_1016_j_hlc_2012_04_002
crossref_primary_10_1111_1742_6723_12156
crossref_primary_10_5312_wjo_v5_i3_188
crossref_primary_10_1097_ALN_0000000000002910
crossref_primary_10_1016_j_thromres_2015_07_012
crossref_primary_10_1007_s00059_012_3622_0
crossref_primary_10_1007_s40138_014_0058_2
crossref_primary_10_1111_ijlh_12065
crossref_primary_10_1016_j_thromres_2016_01_017
crossref_primary_10_1016_j_ijcard_2013_07_152
crossref_primary_10_1160_TH14_08_0712
crossref_primary_10_1002_rth2_12089
crossref_primary_10_1007_s40265_020_01345_5
crossref_primary_10_1160_TH15_03_0222
crossref_primary_10_1186_s13643_018_0838_y
crossref_primary_10_1186_s12959_015_0056_y
crossref_primary_10_1097_ICB_0000000000000167
crossref_primary_10_1093_europace_euv309
crossref_primary_10_1111_ctr_12873
crossref_primary_10_5694_mja12_10614
crossref_primary_10_1111_bjh_15808
crossref_primary_10_4037_ccn2019292
crossref_primary_10_1007_s11239_013_0926_8
crossref_primary_10_1038_nrcardio_2012_19
crossref_primary_10_7861_clinmedicine_14_2_165
crossref_primary_10_1007_s11739_017_1660_6
crossref_primary_10_1016_j_ijcard_2016_03_056
crossref_primary_10_1002_clc_22081
crossref_primary_10_1186_s13054_015_0930_9
crossref_primary_10_1016_j_cld_2016_12_003
crossref_primary_10_1038_clpt_2012_197
crossref_primary_10_1111_jgs_12042
crossref_primary_10_1182_blood_2013_09_529784
crossref_primary_10_1111_ans_12171
crossref_primary_10_1016_j_thromres_2013_03_016
crossref_primary_10_1097_CCM_0b013e31827caaa3
crossref_primary_10_1016_j_jemermed_2019_10_011
crossref_primary_10_7759_cureus_59208
crossref_primary_10_1007_s00210_025_04352_z
crossref_primary_10_1016_j_anclin_2012_11_001
crossref_primary_10_1111_ijlh_12005
crossref_primary_10_1160_TH14_11_0982
crossref_primary_10_3810_hp_2014_10_1152
crossref_primary_10_1002_ajh_23179
crossref_primary_10_1007_s00277_014_2039_7
crossref_primary_10_1373_clinchem_2012_198788
crossref_primary_10_3109_15563650_2012_721888
crossref_primary_10_1111_fcp_12091
crossref_primary_10_1160_th15_03_0266
crossref_primary_10_1007_s11940_013_0248_3
crossref_primary_10_1111_bjh_12502
crossref_primary_10_1007_s10840_012_9677_2
crossref_primary_10_1016_j_ijcard_2018_05_060
crossref_primary_10_1161_CIR_0000000000000477
crossref_primary_10_1007_s00115_019_0695_5
crossref_primary_10_1007_s40267_012_0010_z
crossref_primary_10_1002_ajh_23165
crossref_primary_10_1097_MJT_0000000000000263
crossref_primary_10_1111_jgs_14279
crossref_primary_10_1177_1753944715605011
crossref_primary_10_3810_hp_2012_08_988
crossref_primary_10_1053_j_jvca_2018_07_023
crossref_primary_10_3810_hp_2012_08_986
crossref_primary_10_1007_s00392_013_0560_7
crossref_primary_10_1093_bja_aet401
crossref_primary_10_1186_s13054_016_1413_3
crossref_primary_10_1517_14740338_2012_668524
crossref_primary_10_1111_bjh_13821
crossref_primary_10_1097_TA_0000000000001453
crossref_primary_10_1093_eurheartj_ehy136
crossref_primary_10_1097_TA_0000000000000360
crossref_primary_10_1002_phar_1830
crossref_primary_10_3171_2017_8_FOCUS17421
crossref_primary_10_1016_j_ajem_2017_12_039
crossref_primary_10_1016_j_jacc_2023_08_017
crossref_primary_10_1016_j_nec_2016_11_011
crossref_primary_10_1016_S0049_3848_14_50026_6
crossref_primary_10_1016_j_annemergmed_2016_11_040
crossref_primary_10_1186_s13054_019_2492_8
crossref_primary_10_1007_s11886_017_0930_2
crossref_primary_10_1177_10760296231198038
crossref_primary_10_1016_j_ijcard_2015_09_035
crossref_primary_10_1093_neuros_nyx072
crossref_primary_10_1177_1076029616675970
crossref_primary_10_1182_blood_2017_05_782060
crossref_primary_10_3810_hp_2014_10_1144
crossref_primary_10_1007_s00508_014_0586_5
crossref_primary_10_1586_14779072_2015_1034692
crossref_primary_10_1053_j_ackd_2012_09_003
crossref_primary_10_1002_j_1875_9114_2012_01036_x
crossref_primary_10_1111_j_1751_2824_2012_01592_x
crossref_primary_10_1586_14779072_2013_815423
crossref_primary_10_1007_s11938_020_00331_w
crossref_primary_10_1016_j_pjnns_2015_04_007
crossref_primary_10_1016_j_wneu_2015_11_086
crossref_primary_10_1016_j_jemermed_2017_12_061
crossref_primary_10_1007_s10039_017_0246_x
crossref_primary_10_1007_s40266_014_0212_2
crossref_primary_10_1097_TA_0000000000004345
crossref_primary_10_1111_j_1445_5994_2011_02704_x
crossref_primary_10_1093_eurheartj_ehs408
crossref_primary_10_3171_2013_2_FOCUS1328
crossref_primary_10_1007_s11239_014_1112_3
crossref_primary_10_1007_s11239_021_02536_x
crossref_primary_10_1016_j_cjca_2013_02_021
crossref_primary_10_2217_pme_13_38
crossref_primary_10_1111_trf_14096
crossref_primary_10_1155_2012_108983
crossref_primary_10_21320_1818_474X_2025_2_11_46
crossref_primary_10_1136_heartjnl_2012_301841
crossref_primary_10_1161_CIRCEP_114_001586
crossref_primary_10_1016_j_cll_2014_06_012
crossref_primary_10_1016_j_pop_2012_11_011
crossref_primary_10_1016_j_ajem_2012_05_022
crossref_primary_10_1016_j_annemergmed_2015_07_014
crossref_primary_10_1097_TA_0b013e31829e20bf
crossref_primary_10_1016_j_clinthera_2012_09_008
crossref_primary_10_1016_j_jocn_2014_04_025
crossref_primary_10_1097_MAJ_0b013e318295cc72
crossref_primary_10_1161_STROKEAHA_120_031825
crossref_primary_10_1016_j_amjms_2016_03_018
crossref_primary_10_1371_journal_pone_0195122
crossref_primary_10_1136_heartjnl_2013_305017
crossref_primary_10_1016_S2352_3026_16_30079_5
crossref_primary_10_1097_MBC_0000000000000511
crossref_primary_10_3109_00365513_2014_921930
crossref_primary_10_1016_j_ejim_2011_11_007
crossref_primary_10_1111_trf_15169
crossref_primary_10_1007_s40138_015_0072_z
crossref_primary_10_1161_STROKEAHA_118_021380
crossref_primary_10_1016_j_disamonth_2012_04_003
crossref_primary_10_1111_1755_5922_12048
crossref_primary_10_1160_TH13_12_1032
crossref_primary_10_1007_s00059_012_3616_y
crossref_primary_10_1016_S0120_5633_12_70141_9
crossref_primary_10_1136_postgradmedj_2014_132605
crossref_primary_10_1177_2042098613507945
crossref_primary_10_1177_2192568219852051
crossref_primary_10_1016_j_disamonth_2012_04_007
crossref_primary_10_2174_1381612825666190709220449
crossref_primary_10_1177_1076029614545211
crossref_primary_10_1097_BOT_0b013e318251219c
crossref_primary_10_1097_MBC_0000000000000763
crossref_primary_10_1016_j_thromres_2020_06_044
crossref_primary_10_1097_TME_0000000000000123
crossref_primary_10_1111_j_1538_7836_2012_04863_x
crossref_primary_10_1007_s11239_013_0923_y
crossref_primary_10_1007_s00228_013_1550_4
crossref_primary_10_1093_ckj_sfs068
crossref_primary_10_1038_nrcardio_2013_73
crossref_primary_10_1007_s11940_013_0275_0
crossref_primary_10_1016_j_jemermed_2013_03_016
crossref_primary_10_1093_eurheartj_ehz282
crossref_primary_10_1016_j_clineuro_2018_04_001
crossref_primary_10_1177_1076029612438957
crossref_primary_10_1016_j_ajem_2014_08_028
crossref_primary_10_1160_TH14_02_0138
crossref_primary_10_1016_j_surg_2012_09_016
crossref_primary_10_3810_pgm_2012_11_2608
crossref_primary_10_1186_s12959_015_0037_1
crossref_primary_10_2146_ajhp130634
crossref_primary_10_1016_j_thromres_2016_02_005
crossref_primary_10_1182_blood_2011_10_378950
crossref_primary_10_1136_emermed_2012_201976
crossref_primary_10_1016_j_ajem_2012_04_005
crossref_primary_10_4037_ccn2017476
crossref_primary_10_1016_j_ejim_2013_01_021
crossref_primary_10_1016_j_joa_2012_05_012
crossref_primary_10_1053_j_ajkd_2013_02_361
crossref_primary_10_1007_s40265_013_0174_4
crossref_primary_10_1177_1060028013513883
crossref_primary_10_1080_17474086_2017_1358085
crossref_primary_10_1177_1076029613494468
crossref_primary_10_1016_j_suc_2017_11_001
crossref_primary_10_1097_MCC_0000000000000317
crossref_primary_10_1097_EJA_0000000000000630
crossref_primary_10_1007_s40119_013_0016_1
crossref_primary_10_1016_j_amjmed_2012_07_001
crossref_primary_10_1053_j_seminhematol_2014_02_002
crossref_primary_10_1055_a_1246_3423
crossref_primary_10_1111_1742_6723_12235
crossref_primary_10_1177_1076029613503397
crossref_primary_10_1016_j_jcin_2014_06_014
crossref_primary_10_1097_01_CSS_0000427481_67868_ce
crossref_primary_10_1053_j_seminhematol_2014_02_001
crossref_primary_10_2459_JCM_0000000000000524
crossref_primary_10_1053_j_jvca_2012_03_029
crossref_primary_10_1177_0897190012452309
crossref_primary_10_1007_s11239_013_0958_0
crossref_primary_10_1097_CCM_0000000000005059
crossref_primary_10_1111_sdi_12376
crossref_primary_10_1177_2048004020915406
crossref_primary_10_1007_s11926_017_0676_2
crossref_primary_10_1177_1074248414525505
crossref_primary_10_1053_j_ajkd_2013_02_381
crossref_primary_10_1177_0885066614527417
crossref_primary_10_1016_j_ajem_2020_08_019
crossref_primary_10_1345_aph_1R720
crossref_primary_10_1345_aph_1R724
crossref_primary_10_1016_j_surg_2012_09_008
crossref_primary_10_1111_trf_15117
crossref_primary_10_1016_j_wem_2014_01_007
crossref_primary_10_1016_j_tcm_2012_10_001
crossref_primary_10_3171_2013_2_FOCUS1323
crossref_primary_10_1016_j_cnc_2017_04_005
crossref_primary_10_1016_j_jaad_2014_11_013
crossref_primary_10_1002_ams2_123
crossref_primary_10_1007_s13341_014_0410_x
crossref_primary_10_3810_hp_2014_12_1164
crossref_primary_10_1053_j_jvca_2014_06_003
crossref_primary_10_1097_01_JAA_0000529772_90897_d6
crossref_primary_10_1111_j_1755_5949_2012_00329_x
crossref_primary_10_1186_s40560_014_0060_5
crossref_primary_10_1160_TH11_11_0804
crossref_primary_10_1160_TH12_06_0440
crossref_primary_10_1007_s12028_019_00898_y
crossref_primary_10_1007_s40265_013_0056_9
crossref_primary_10_1016_S1474_4422_12_70258_2
crossref_primary_10_3810_hp_2013_02_1010
crossref_primary_10_1097_ALN_0000000000005515
crossref_primary_10_1097_ALN_0000000000000061
crossref_primary_10_1586_17474086_2013_853430
crossref_primary_10_5402_2012_376071
crossref_primary_10_1016_j_beha_2012_06_004
crossref_primary_10_3109_07853890_2014_912833
crossref_primary_10_1016_j_hoc_2017_08_012
crossref_primary_10_1177_1076029616634886
crossref_primary_10_1039_C9RA07825H
crossref_primary_10_1258_phleb_2012_012s33
crossref_primary_10_1080_17425255_2021_1965124
crossref_primary_10_1016_j_ahj_2014_04_007
crossref_primary_10_1007_s10840_016_0214_6
crossref_primary_10_1093_ehjcr_ytaa482
crossref_primary_10_1016_j_ahj_2014_04_005
crossref_primary_10_1155_cdr_2208110
crossref_primary_10_1053_j_seminhematol_2013_06_005
crossref_primary_10_1097_MOH_0000000000000084
crossref_primary_10_1177_0897190015613231
crossref_primary_10_1177_1076029612458148
crossref_primary_10_1080_21548331_2015_1103190
crossref_primary_10_1097_MCC_0b013e32835444bc
crossref_primary_10_1097_MEJ_0000000000000400
crossref_primary_10_1016_j_ajem_2014_04_031
crossref_primary_10_1177_1120700019841351
crossref_primary_10_1016_j_cjca_2013_04_013
crossref_primary_10_1016_j_ajem_2021_01_086
crossref_primary_10_1016_j_berh_2014_02_003
crossref_primary_10_1007_s00105_012_2369_0
crossref_primary_10_1155_2013_183616
crossref_primary_10_1016_S1441_2772_23_00384_8
crossref_primary_10_1097_TA_0b013e31827019c9
crossref_primary_10_1007_s00068_014_0404_9
crossref_primary_10_1056_NEJMra1206531
crossref_primary_10_1111_fcp_12992
crossref_primary_10_1093_eurheartj_sux026
crossref_primary_10_1016_j_thromres_2022_06_005
crossref_primary_10_1186_1477_9560_11_27
crossref_primary_10_1002_rth2_12418
crossref_primary_10_1517_14740338_2013_732569
crossref_primary_10_1097_MAJ_0b013e3182429b1e
crossref_primary_10_1097_IOP_0000000000000572
crossref_primary_10_3109_07853890_2013_801274
crossref_primary_10_1016_j_ajem_2014_08_075
crossref_primary_10_1093_eurheartj_ehs258
crossref_primary_10_1093_eurheartj_ehs253
crossref_primary_10_1007_s11239_021_02412_8
crossref_primary_10_3928_01477447_20120525_38
crossref_primary_10_2146_ajhp120617
crossref_primary_10_1007_s00391_012_0377_4
crossref_primary_10_1016_j_tmrv_2015_08_001
crossref_primary_10_1016_j_ajem_2013_11_044
crossref_primary_10_1097_MCP_0b013e32835466eb
crossref_primary_10_1097_EJA_0b013e32835f4d5b
crossref_primary_10_1111_cts_12398
crossref_primary_10_1016_j_annemergmed_2024_02_003
crossref_primary_10_14423_SMJ_0000000000000552
crossref_primary_10_1002_phar_1133
crossref_primary_10_1016_j_jemermed_2012_12_022
crossref_primary_10_1016_j_ijcard_2012_08_014
crossref_primary_10_1177_2396987319849763
crossref_primary_10_2146_ajhp130243
crossref_primary_10_1007_s00399_014_0304_z
crossref_primary_10_1016_j_thromres_2017_12_003
crossref_primary_10_1007_s00063_016_0241_1
crossref_primary_10_1136_svn_2019_000274
crossref_primary_10_1007_s12028_017_0456_x
crossref_primary_10_1007_s40266_013_0094_8
crossref_primary_10_1016_j_jmv_2012_09_003
crossref_primary_10_1016_j_thromres_2014_01_031
crossref_primary_10_1111_jth_14838
crossref_primary_10_1007_s40264_015_0357_x
crossref_primary_10_1310_hpj4811_951
crossref_primary_10_1097_MJT_0b013e3182878d18
crossref_primary_10_1160_TH12_03_0209
crossref_primary_10_1016_j_accpm_2018_04_009
crossref_primary_10_1016_j_bpa_2013_02_004
crossref_primary_10_1097_ACO_0000000000000100
crossref_primary_10_1007_s40256_015_0127_2
crossref_primary_10_1017_S0022215120000754
crossref_primary_10_1007_s40138_018_0157_6
crossref_primary_10_1016_j_suc_2013_05_003
crossref_primary_10_1097_ALN_0000000000000255
crossref_primary_10_1016_j_thromres_2014_01_017
crossref_primary_10_1160_TH13_05_0431
crossref_primary_10_1016_j_jns_2017_01_041
crossref_primary_10_1016_j_jemermed_2012_11_032
crossref_primary_10_1517_14656566_2013_773310
crossref_primary_10_1007_s11239_020_02154_z
crossref_primary_10_1186_s12245_015_0059_2
crossref_primary_10_4137_CMC_S8204
crossref_primary_10_1007_s11239_024_03052_4
crossref_primary_10_1002_clc_22204
crossref_primary_10_1016_j_ajem_2016_09_046
crossref_primary_10_1007_s40138_013_0026_2
crossref_primary_10_3810_hp_2012_04_973
crossref_primary_10_1007_s11239_013_0967_z
crossref_primary_10_1093_eurheartj_suv061
crossref_primary_10_1302_0301_620X_97B4_35230
crossref_primary_10_1002_rth2_12699
crossref_primary_10_1007_s11739_013_0949_3
crossref_primary_10_1177_0141076813498232
crossref_primary_10_1016_j_wneu_2015_08_042
crossref_primary_10_1016_j_thromres_2018_08_014
crossref_primary_10_1016_j_thromres_2021_10_026
crossref_primary_10_1097_ALN_0b013e318289bcba
crossref_primary_10_1310_hpj5007_569
crossref_primary_10_1007_s40256_016_0161_8
crossref_primary_10_1007_s11239_015_1296_1
crossref_primary_10_1097_MNH_0000000000000098
crossref_primary_10_1002_clc_22434
crossref_primary_10_1016_j_cll_2014_06_007
crossref_primary_10_1093_eurheartj_ehv320
crossref_primary_10_1177_0961203315581207
crossref_primary_10_1016_j_lpm_2013_11_025
crossref_primary_10_1185_03007995_2014_936931
crossref_primary_10_1007_s12325_012_0026_8
crossref_primary_10_1016_j_cll_2014_06_004
crossref_primary_10_1016_j_cll_2014_06_001
crossref_primary_10_3810_hp_2012_10_999
crossref_primary_10_1007_s11886_012_0296_4
crossref_primary_10_1016_j_pharmthera_2012_02_006
crossref_primary_10_1002_clc_22582
crossref_primary_10_2146_ajhp130042
crossref_primary_10_5858_arpa_2013_0677_RS
crossref_primary_10_1111_jth_13139
crossref_primary_10_1345_aph_1R081
crossref_primary_10_1185_03007995_2014_951425
crossref_primary_10_2146_ajhp130041
crossref_primary_10_1016_j_jtha_2022_11_029
crossref_primary_10_1007_s00063_013_0243_1
crossref_primary_10_1517_14740338_2013_799663
crossref_primary_10_1093_europace_eut083
crossref_primary_10_1097_ACO_0b013e32834e46b1
crossref_primary_10_1177_00185787241229192
crossref_primary_10_1016_S0140_6736_15_61086_8
crossref_primary_10_1097_TA_0b013e3182a07391
crossref_primary_10_1016_j_jocn_2013_05_009
crossref_primary_10_1002_jppr_1104
crossref_primary_10_1016_S1474_4422_12_70157_6
crossref_primary_10_1093_europace_euv030
crossref_primary_10_2217_cpr_13_7
crossref_primary_10_1007_s00391_013_0595_4
crossref_primary_10_1186_1756_8722_4_53
crossref_primary_10_1002_rth2_12367
crossref_primary_10_1038_nrcardio_2017_223
crossref_primary_10_1111_jth_13115
crossref_primary_10_1016_j_jacc_2019_07_065
crossref_primary_10_1007_s40262_012_0030_9
crossref_primary_10_1002_jhm_2007
crossref_primary_10_1007_s11940_016_0430_5
crossref_primary_10_1111_pace_13013
crossref_primary_10_1093_eurheartj_ehu282
crossref_primary_10_2165_11209080_000000000_00000
crossref_primary_10_5482_ha_2012030004
crossref_primary_10_1186_s12878_015_0039_z
crossref_primary_10_1016_S1878_6480_14_71480_6
crossref_primary_10_1136_gutjnl_2018_317807
crossref_primary_10_1007_s10840_014_9910_2
crossref_primary_10_1007_s11936_013_0242_9
crossref_primary_10_1182_blood_2018_06_850396
crossref_primary_10_1016_j_jen_2014_04_016
crossref_primary_10_1016_j_annemergmed_2023_04_015
crossref_primary_10_1002_phar_1532
crossref_primary_10_1016_j_chroma_2018_02_050
crossref_primary_10_1182_blood_2018_06_820746
crossref_primary_10_1186_s13054_016_1275_8
crossref_primary_10_1016_j_beha_2013_07_001
crossref_primary_10_1016_j_emc_2018_04_014
crossref_primary_10_1160_TH12_03_0179
crossref_primary_10_1007_s12028_015_0222_x
crossref_primary_10_1586_17512433_2013_842125
crossref_primary_10_1038_clpt_2013_83
crossref_primary_10_1161_STROKEAHA_111_000387
crossref_primary_10_1111_j_1538_7836_2012_04859_x
crossref_primary_10_1111_jth_12485
crossref_primary_10_1080_03007995_2017_1364227
crossref_primary_10_1016_j_ajem_2012_08_015
crossref_primary_10_1517_14728214_2013_777427
crossref_primary_10_1016_j_lpm_2013_06_001
crossref_primary_10_1097_MCA_0000000000000387
crossref_primary_10_1002_ajh_23202
crossref_primary_10_1016_j_cger_2012_08_003
crossref_primary_10_1016_j_emc_2013_10_001
crossref_primary_10_1177_2040622312438934
crossref_primary_10_1016_j_jcrc_2018_08_031
crossref_primary_10_1177_1076029612454938
crossref_primary_10_1002_ajh_23208
crossref_primary_10_1016_j_ancard_2012_10_001
crossref_primary_10_1016_j_chest_2018_07_040
crossref_primary_10_1097_HPC_0b013e31829834ed
crossref_primary_10_1111_bcp_12220
crossref_primary_10_1080_14779072_2018_1484281
crossref_primary_10_1007_s11926_013_0331_5
crossref_primary_10_1177_2040620712453067
crossref_primary_10_5339_gcsp_2013_24
crossref_primary_10_1080_15563650_2016_1187736
crossref_primary_10_2146_ajhp120493
crossref_primary_10_1007_s11883_012_0259_7
crossref_primary_10_1016_j_hrcr_2019_11_010
crossref_primary_10_1080_14712598_2019_1599355
crossref_primary_10_1258_cvd_2012_012018
crossref_primary_10_1053_j_ajkd_2017_08_011
crossref_primary_10_1016_j_annemergmed_2017_08_037
crossref_primary_10_1097_TXD_0000000000000843
crossref_primary_10_1177_0885066618800657
crossref_primary_10_1097_MOH_0b013e328365a164
crossref_primary_10_1111_jth_12227
crossref_primary_10_1093_eurheartj_ehu083
crossref_primary_10_1007_s10741_012_9343_x
crossref_primary_10_1016_j_revmed_2012_01_007
crossref_primary_10_1016_j_biologicals_2015_01_001
crossref_primary_10_1093_qjmed_hcr214
crossref_primary_10_1007_s11239_015_1167_9
crossref_primary_10_1093_eurheartj_ehad123
crossref_primary_10_1016_j_jviscsurg_2014_01_009
crossref_primary_10_1136_gutjnl_2017_315131
crossref_primary_10_1016_j_emc_2012_06_003
crossref_primary_10_1097_HPC_0000000000000181
crossref_primary_10_1111_jth_12236
crossref_primary_10_1016_j_acvd_2013_04_009
crossref_primary_10_1007_s40256_015_0124_5
crossref_primary_10_1177_0885066619840992
crossref_primary_10_1586_14779072_2016_1115344
crossref_primary_10_1111_jcpt_12122
crossref_primary_10_1160_TH12_03_0149
crossref_primary_10_1007_s13670_016_0153_1
crossref_primary_10_1186_s40560_018_0303_y
crossref_primary_10_1186_cc13889
crossref_primary_10_3109_02688697_2015_1029433
crossref_primary_10_1016_j_mayocp_2013_03_006
crossref_primary_10_1093_eurheartj_ehw058
crossref_primary_10_1002_ajh_23254
crossref_primary_10_1177_1756283X17702092
crossref_primary_10_2146_ajhp150966
crossref_primary_10_1007_s13311_011_0091_8
crossref_primary_10_1016_j_jemermed_2013_11_097
crossref_primary_10_1111_trf_14933
crossref_primary_10_1007_s00540_019_02653_1
crossref_primary_10_1016_j_crvasa_2013_01_005
crossref_primary_10_1097_ALN_0000000000000863
crossref_primary_10_1111_bjh_15705
crossref_primary_10_1002_slct_202201710
crossref_primary_10_1111_pace_12553
crossref_primary_10_5114_ait_2021_110608
crossref_primary_10_5114_ait_2021_110607
crossref_primary_10_1016_j_thromres_2023_01_022
crossref_primary_10_1038_nm_3102
crossref_primary_10_1161_ATVBAHA_114_303402
crossref_primary_10_1097_EJA_0000000000000150
crossref_primary_10_1177_08971900221131924
crossref_primary_10_1002_clc_22173
crossref_primary_10_1517_14656566_2015_1074179
crossref_primary_10_1016_j_bjps_2016_02_011
crossref_primary_10_1007_s12306_013_0306_8
crossref_primary_10_1160_TH11_09_0668
crossref_primary_10_1007_s00063_015_0082_3
crossref_primary_10_1007_s11739_014_1051_1
crossref_primary_10_2215_CJN_01260213
crossref_primary_10_5694_mja12_10729
crossref_primary_10_1177_1074248415576193
crossref_primary_10_1016_j_mcna_2015_02_006
crossref_primary_10_1002_jcph_1779
crossref_primary_10_1055_s_0040_1709134
crossref_primary_10_1111_aas_12319
crossref_primary_10_2146_ajhp120055
crossref_primary_10_1053_j_jvca_2017_12_039
crossref_primary_10_1016_j_avsg_2013_07_013
crossref_primary_10_1007_s00228_013_1510_z
crossref_primary_10_1093_ageing_afz070
crossref_primary_10_2165_11641160_000000000_00000
crossref_primary_10_1007_s11239_013_0991_z
crossref_primary_10_1186_s12903_016_0170_7
crossref_primary_10_1161_STROKEAHA_118_023840
crossref_primary_10_1016_j_ijcard_2014_07_084
crossref_primary_10_1378_chest_12_1362
crossref_primary_10_1016_j_hrcr_2019_12_003
crossref_primary_10_1111_aas_12303
crossref_primary_10_1111_bjh_13974
crossref_primary_10_1177_000313481408000419
crossref_primary_10_1016_j_tmrv_2017_07_002
crossref_primary_10_1007_s12028_020_00968_6
crossref_primary_10_1007_s00277_015_2566_x
crossref_primary_10_1007_s40256_013_0007_6
crossref_primary_10_1016_j_cjca_2014_01_015
crossref_primary_10_1136_heartjnl_2013_304347
crossref_primary_10_4037_ccn2019160
crossref_primary_10_7556_jaoa_2015_122
crossref_primary_10_1016_j_jacc_2020_04_053
crossref_primary_10_1007_s11239_015_1321_4
crossref_primary_10_1186_cc12592
crossref_primary_10_1053_j_jvca_2017_05_017
crossref_primary_10_1177_10760296221078842
crossref_primary_10_1182_bloodadvances_2017007112
crossref_primary_10_1111_jce_12918
crossref_primary_10_1016_j_ajem_2014_01_042
crossref_primary_10_1016_j_drudis_2022_07_017
crossref_primary_10_1097_HPC_0b013e31825298ef
crossref_primary_10_1016_j_tmrv_2015_03_003
crossref_primary_10_1111_j_1538_7836_2012_04866_x
crossref_primary_10_2146_ajhp160980
crossref_primary_10_1016_j_gtc_2014_08_002
crossref_primary_10_1310_hpj5101_26
crossref_primary_10_1016_j_itjm_2012_02_001
crossref_primary_10_1160_TH12_11_0803
crossref_primary_10_1111_ans_12070
crossref_primary_10_1160_TH11_10_0690
crossref_primary_10_1308_003588414X13824511649779
crossref_primary_10_1111_ans_12078
crossref_primary_10_1186_1752_1947_6_129
crossref_primary_10_1373_clinchem_2012_189704
crossref_primary_10_1016_j_ejvs_2014_07_007
crossref_primary_10_1177_1076029613479819
crossref_primary_10_1002_jhm_2201
crossref_primary_10_5482_HAMO_16_11_0043
crossref_primary_10_1016_j_hrtlng_2013_10_014
crossref_primary_10_1016_j_jhep_2013_03_027
crossref_primary_10_1016_j_thromres_2014_12_019
crossref_primary_10_1160_TH11_12_0859
crossref_primary_10_1309_AJCPQOD9WFPEYY0H
crossref_primary_10_1007_s11239_015_1310_7
crossref_primary_10_1007_s11739_017_1628_6
crossref_primary_10_1016_j_ccc_2021_03_012
crossref_primary_10_5937_arhfarm2005310T
crossref_primary_10_1016_j_surg_2018_05_060
crossref_primary_10_1080_14656566_2016_1268122
crossref_primary_10_2146_ajhp150960
crossref_primary_10_1160_TH12_05_0298
crossref_primary_10_1038_nrcardio_2014_222
crossref_primary_10_1177_2050312117734773
crossref_primary_10_1111_jth_13165
crossref_primary_10_1007_s11239_018_1617_2
crossref_primary_10_1160_th15_02_0181
crossref_primary_10_1177_1060028020962115
crossref_primary_10_1007_s11886_014_0480_9
crossref_primary_10_1080_21548331_2017_1298389
crossref_primary_10_1111_jth_13815
crossref_primary_10_1007_s00101_013_2233_3
crossref_primary_10_1007_s10557_014_6524_y
crossref_primary_10_1016_j_crvasa_2013_03_002
crossref_primary_10_1017_S0022215115002765
crossref_primary_10_1111_imj_12448
crossref_primary_10_2310_8000_2013_131073
crossref_primary_10_1182_blood_2012_12_453076
crossref_primary_10_1016_j_amjmed_2016_06_003
crossref_primary_10_1016_j_cgh_2018_08_009
crossref_primary_10_1007_s11936_013_0238_5
crossref_primary_10_1016_j_clinthera_2012_02_022
crossref_primary_10_1097_AAP_0000000000000223
crossref_primary_10_1161_CIRCULATIONAHA_113_008428
crossref_primary_10_1155_2014_583794
crossref_primary_10_1007_s13181_013_0364_1
crossref_primary_10_1016_j_jcrc_2017_09_178
crossref_primary_10_1016_j_thromres_2015_01_007
crossref_primary_10_3810_pgm_2013_01_2622
crossref_primary_10_1016_j_injury_2019_08_035
crossref_primary_10_1310_hpj4805_366
crossref_primary_10_1161_CIRCINTERVENTIONS_113_000343
crossref_primary_10_1177_0885066613488732
crossref_primary_10_1002_phar_1289
crossref_primary_10_1177_1060028013513722
crossref_primary_10_5482_HAMO_13_02_0005
crossref_primary_10_5811_cpcem_2018_2_37096
crossref_primary_10_1053_j_jvca_2011_10_005
crossref_primary_10_1177_0897190015627116
crossref_primary_10_1016_j_heliyon_2024_e39347
crossref_primary_10_1186_s12245_018_0215_6
crossref_primary_10_1160_TH13_09_0741
crossref_primary_10_1161_STR_0000000000000069
crossref_primary_10_2217_fca_2016_0070
crossref_primary_10_1111_jth_12949
crossref_primary_10_1016_j_jemermed_2016_08_023
crossref_primary_10_1016_j_thromres_2014_07_003
crossref_primary_10_1007_s40140_018_0253_x
crossref_primary_10_1016_j_ajem_2022_04_044
crossref_primary_10_1111_ane_13685
crossref_primary_10_2215_CJN_02170218
crossref_primary_10_1016_j_wneu_2012_06_019
crossref_primary_10_1016_S1474_4422_13_70049_8
crossref_primary_10_12998_wjcc_v2_i8_362
crossref_primary_10_1007_s00408_016_9898_8
crossref_primary_10_1016_j_jcrc_2016_06_024
crossref_primary_10_1016_j_thromres_2024_109172
crossref_primary_10_3810_pgm_2012_07_2581
crossref_primary_10_1556_OH_2012_29505
crossref_primary_10_1016_j_jemermed_2012_02_042
crossref_primary_10_1097_NRL_0b013e318247bcb6
crossref_primary_10_1097_MJT_0000000000000121
crossref_primary_10_1053_j_ajkd_2017_03_025
crossref_primary_10_1161_CIR_0000000000001193
crossref_primary_10_1016_j_biotechadv_2016_07_004
crossref_primary_10_1016_j_dld_2020_04_032
crossref_primary_10_1136_flgastro_2013_100325
crossref_primary_10_1159_000502173
crossref_primary_10_1186_s12959_017_0129_1
crossref_primary_10_1093_ajhp_zxac079
crossref_primary_10_1016_j_jsha_2015_05_003
crossref_primary_10_1136_bcr_2016_218015
crossref_primary_10_1136_ejhpharm_2023_003892
crossref_primary_10_1515_cclm_2012_0327
crossref_primary_10_1097_ACO_0000000000000294
crossref_primary_10_1177_1076029618796339
crossref_primary_10_1160_TH12_04_0222
crossref_primary_10_1586_erc_12_18
crossref_primary_10_1111_j_1600_0609_2011_01733_x
crossref_primary_10_1586_erc_12_19
crossref_primary_10_1016_j_jemermed_2025_05_013
crossref_primary_10_1007_s12254_016_0284_2
crossref_primary_10_3810_pgm_2013_05_2670
crossref_primary_10_3390_jcm7020029
crossref_primary_10_1111_trf_15259
crossref_primary_10_1007_s00508_013_0430_3
crossref_primary_10_1016_j_ajem_2017_08_042
crossref_primary_10_1016_j_athoracsur_2017_12_001
crossref_primary_10_1007_BF03261837
crossref_primary_10_1111_j_1537_2995_2012_03690_x
crossref_primary_10_1016_j_thromres_2017_04_027
crossref_primary_10_1016_j_jstrokecerebrovasdis_2018_02_014
crossref_primary_10_1111_acem_12225
crossref_primary_10_1097_ALN_0000000000002399
crossref_primary_10_4037_ajcc2013125
crossref_primary_10_1097_MEJ_0000000000000322
crossref_primary_10_1177_0897190012465989
crossref_primary_10_5858_arpa_2014_0366_RS
crossref_primary_10_1371_journal_pone_0137444
crossref_primary_10_1586_14779072_2014_931223
crossref_primary_10_1016_S0870_2551_12_70034_3
crossref_primary_10_1097_MOH_0b013e328363c170
crossref_primary_10_1016_j_jacc_2011_11_044
crossref_primary_10_1053_j_ajkd_2015_01_022
crossref_primary_10_1160_th15_05_0415
crossref_primary_10_1161_CIRCULATIONAHA_113_005376
crossref_primary_10_1186_s13054_016_1422_2
crossref_primary_10_1155_2014_935474
crossref_primary_10_1002_msj_21346
crossref_primary_10_1177_1076029616638506
crossref_primary_10_1016_j_thromres_2018_01_006
crossref_primary_10_1016_j_hrthm_2015_02_028
crossref_primary_10_1007_s11936_014_0326_1
crossref_primary_10_1016_j_blre_2016_08_006
crossref_primary_10_1007_s10620_018_5427_3
crossref_primary_10_1016_j_clinthera_2012_01_019
crossref_primary_10_1016_j_thromres_2012_05_025
crossref_primary_10_1007_s40262_013_0100_7
crossref_primary_10_1016_j_jemermed_2015_02_052
crossref_primary_10_1111_j_1538_7836_2011_04432_x
crossref_primary_10_3390_ph5020155
crossref_primary_10_1093_qjmed_hcs114
crossref_primary_10_3810_hp_2014_08_1117
crossref_primary_10_1136_gutjnl_2015_311110
crossref_primary_10_1111_ijs_12158
crossref_primary_10_1002_ddr_21097
crossref_primary_10_1309_AJCP9VJS6KUKNCHW
crossref_primary_10_1080_21548331_2015_998157
crossref_primary_10_1111_jth_13894
crossref_primary_10_1177_1076029614561321
crossref_primary_10_1016_j_annfar_2013_04_016
crossref_primary_10_1007_s12630_017_0868_2
crossref_primary_10_1007_s00101_012_2136_8
crossref_primary_10_1016_j_gie_2013_04_179
crossref_primary_10_1007_s11940_014_0309_2
crossref_primary_10_1182_bloodadvances_2018024133
crossref_primary_10_4997_jrcpe_2016_211
crossref_primary_10_1016_j_ijcard_2015_03_369
crossref_primary_10_1016_j_jstrokecerebrovasdis_2018_04_004
crossref_primary_10_1161_CIRCULATIONAHA_114_013445
crossref_primary_10_3810_hp_2014_08_1120
crossref_primary_10_1097_EJA_0000000000001803
crossref_primary_10_1097_EJA_0000000000001804
crossref_primary_10_1517_14656566_2014_938638
crossref_primary_10_3171_2012_7_JNS12650
crossref_primary_10_1016_j_amjopharm_2012_02_004
crossref_primary_10_1002_ana_25134
crossref_primary_10_1016_j_jacc_2012_02_008
crossref_primary_10_1160_TH13_05_0357
crossref_primary_10_1016_j_annfar_2013_07_009
crossref_primary_10_1016_j_drudis_2014_05_013
crossref_primary_10_1016_j_emc_2017_07_002
crossref_primary_10_1007_s00059_012_3619_8
crossref_primary_10_1016_j_tcm_2019_03_004
crossref_primary_10_1053_j_gastro_2013_05_025
crossref_primary_10_1016_j_ahj_2016_01_010
crossref_primary_10_1055_s_0042_1753485
crossref_primary_10_1007_s11940_017_0438_5
crossref_primary_10_1097_CNQ_0000000000000399
crossref_primary_10_1177_0897190012465955
crossref_primary_10_1097_CCM_0000000000000909
crossref_primary_10_1177_0897190012465950
crossref_primary_10_1002_rth2_12775
crossref_primary_10_1111_jcpt_12719
crossref_primary_10_1213_XAA_0000000000000143
crossref_primary_10_3810_hp_2014_02_1090
crossref_primary_10_1016_S0140_6736_13_60596_6
crossref_primary_10_1016_j_annfar_2012_10_034
crossref_primary_10_1007_s12028_017_0453_0
crossref_primary_10_1007_s40266_013_0101_0
crossref_primary_10_1097_ACO_0000000000000041
crossref_primary_10_1016_j_pcad_2015_07_003
crossref_primary_10_1016_j_coph_2016_02_008
crossref_primary_10_1002_j_2396_8397_2013_tb00012_x
crossref_primary_10_1093_bja_aew259
crossref_primary_10_1186_s12959_020_00228_9
crossref_primary_10_1007_s00508_014_0581_x
crossref_primary_10_1177_0961203312458843
crossref_primary_10_1097_ALN_0000000000003899
crossref_primary_10_1586_14779072_2014_910118
crossref_primary_10_1016_j_thromres_2011_12_014
crossref_primary_10_1016_j_hoc_2016_05_006
crossref_primary_10_1097_ACO_0000000000000697
crossref_primary_10_1161_STROKEAHA_112_675231
crossref_primary_10_1586_14779072_2015_987126
crossref_primary_10_1016_j_ijcard_2015_03_323
crossref_primary_10_1007_s40256_016_0162_7
crossref_primary_10_1016_j_crvasa_2012_12_002
crossref_primary_10_4103_0975_3583_102690
crossref_primary_10_1016_j_jacc_2015_01_049
crossref_primary_10_1161_CIRCRESAHA_121_319949
crossref_primary_10_1007_s12185_015_1739_7
crossref_primary_10_1053_j_ajkd_2012_08_047
crossref_primary_10_1111_ner_12542
crossref_primary_10_1007_s40138_013_0014_6
crossref_primary_10_1016_j_athoracsur_2014_01_077
crossref_primary_10_1016_j_jcrc_2013_06_013
crossref_primary_10_2146_ajhp110725
crossref_primary_10_1002_phar_1270
crossref_primary_10_1007_s11886_015_0626_4
crossref_primary_10_1007_s40292_013_0011_6
crossref_primary_10_1016_j_hrtlng_2015_02_006
crossref_primary_10_1097_CNQ_0000000000000193
crossref_primary_10_1097_MBC_0000000000000203
crossref_primary_10_1097_PEC_0000000000002847
crossref_primary_10_1016_j_jeurea_2014_10_005
crossref_primary_10_1002_rth2_12336
crossref_primary_10_1016_j_amjms_2018_01_013
crossref_primary_10_1016_j_thromres_2017_06_006
crossref_primary_10_1016_j_ahj_2014_12_008
crossref_primary_10_1016_j_annemergmed_2019_05_033
crossref_primary_10_1016_j_bpa_2015_11_007
crossref_primary_10_1517_17425255_2012_688026
crossref_primary_10_1016_j_jen_2013_01_016
crossref_primary_10_1097_MJT_0000000000000726
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/CIRCULATIONAHA.111.029017
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
ExternalDocumentID 21900088
Genre Randomized Controlled Trial
Journal Article
Comparative Study
GroupedDBID ---
.-D
.3C
.55
.XZ
.Z2
01R
0R~
0ZK
18M
1J1
29B
2FS
2WC
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAEJM
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AARTV
AASOK
AAUEB
AAWTL
AAXQO
ABBUW
ABDIG
ABJNI
ABOCM
ABPMR
ABPXF
ABQRW
ABXVJ
ABZAD
ACCJW
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACOAL
ACRKK
ACWDW
ACWRI
ACXNZ
ACZKN
ADBBV
ADCYY
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFCHL
AFDTB
AFEXH
AFFNX
AFNMH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJJEV
AJNWD
AJNYG
AJZMW
ALKUP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMNEI
ASPBG
AVWKF
AYCSE
AZFZN
BAWUL
BOYCO
BQLVK
BYPQX
C45
CGR
CS3
CUY
CVF
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
ECM
EIF
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GX1
H0~
H13
HZ~
IKREB
IKYAY
IN~
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
NPM
N~7
N~B
O9-
OAG
OAH
OBH
OCB
ODMTH
OGEVE
OHH
OHYEH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
RAH
RLZ
S4R
S4S
T8P
TEORI
TR2
UPT
V2I
VVN
W2D
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YOC
YSK
YYM
YZZ
ZFV
ZY1
ZZMQN
~H1
7X8
ADKSD
ID FETCH-LOGICAL-c346t-9cf4e6efa2dd50cc688dd3e4d09d7f51b90001b26b5b824711099e509606e3f62
IEDL.DBID 7X8
ISICitedReferencesCount 1091
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000295609200020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1524-4539
IngestDate Mon Sep 08 06:25:48 EDT 2025
Mon Jul 21 06:06:06 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 14
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c346t-9cf4e6efa2dd50cc688dd3e4d09d7f51b90001b26b5b824711099e509606e3f62
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
PMID 21900088
PQID 896393184
PQPubID 23479
ParticipantIDs proquest_miscellaneous_896393184
pubmed_primary_21900088
PublicationCentury 2000
PublicationDate 2011-10-04
PublicationDateYYYYMMDD 2011-10-04
PublicationDate_xml – month: 10
  year: 2011
  text: 2011-10-04
  day: 04
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 2011
References 21969317 - Circulation. 2011 Oct 4;124(14):1508-10
22529072 - Circulation. 2012 Apr 24;125(16):e614; author reply e616
22529073 - Circulation. 2012 Apr 24;125(16):e615; author reply e616
References_xml – reference: 22529072 - Circulation. 2012 Apr 24;125(16):e614; author reply e616
– reference: 21969317 - Circulation. 2011 Oct 4;124(14):1508-10
– reference: 22529073 - Circulation. 2012 Apr 24;125(16):e615; author reply e616
SSID ssj0006375
Score 2.5996542
Snippet Rivaroxaban and dabigatran are new oral anticoagulants that specifically inhibit factor Xa and thrombin, respectively. Clinical studies on the prevention and...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1573
SubjectTerms Adult
Anticoagulants - antagonists & inhibitors
Antidotes - pharmacology
Benzimidazoles - antagonists & inhibitors
beta-Alanine - analogs & derivatives
beta-Alanine - antagonists & inhibitors
Blood Coagulation - drug effects
Blood Coagulation Factors - pharmacology
Cross-Over Studies
Dabigatran
Double-Blind Method
Endopeptidases
Factor Xa Inhibitors
Humans
Male
Morpholines - antagonists & inhibitors
Partial Thromboplastin Time
Prothrombin Time
Rivaroxaban
Thiophenes - antagonists & inhibitors
Thrombin - antagonists & inhibitors
Thrombin Time
Young Adult
Title Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects
URI https://www.ncbi.nlm.nih.gov/pubmed/21900088
https://www.proquest.com/docview/896393184
Volume 124
WOSCitedRecordID wos000295609200020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fS9xAEB7aKtKXWrXWH20ZQXzq1lyy-eWLHEfFgh4iCvd27O5s8MBL9HKK51_hn-zsJmefxAdfEgjZJTCT-WZ3vv0GYFeRJsWwK4idRUgTB0InRos0zwJShWQI9iKuJ2m_nw0G-VnLzalbWuU8JvpATZVxe-T7GXtKzg4oD29uhWsa5YqrbQeNj7AQcSbjnDod_BcLTyKvs8sIJYWMo3wJdnyMSDr7vX_nvcuTRm_2uOvixp_AVRTT1xNNDzhHy-_81K_wpc00sdu4xgp8sOUqrHVLXmWPZ7iHnvvpN9VXYem0LbGvwdO5dUwNHlkVOBndq0n1oLQqUZWEpLST5GB8Qz1Dp_FwNanGvLhGT023D3wvG77n1B6gQn6TqvHo0dJv9PQvXYmWHX_tnnmQdixS9Dq3yDM1JzNnWN9pt0dUf4PLo78XvWPRtm0QJpLJVOSmkDaxhQqJ4sCYJMuIIispyCkt4o52fUo7Okx0rLOQwdEV52zs11I2KpJwHT6VVWk3AGMTGk4RKQitkjyv5nxNUqipo2SQSbsJOLfAkH8LV-tQpa3u6uGLDTbhe2PF4U0j3zHkGO0yn2zr7cHb8Dmcc_7kD1goOCTYn7Bo7qejevLLuxtf-2enz4yY4nQ
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reversal+of+rivaroxaban+and+dabigatran+by+prothrombin+complex+concentrate%3A+a+randomized%2C+placebo-controlled%2C+crossover+study+in+healthy+subjects&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Eerenberg%2C+Elise+S&rft.au=Kamphuisen%2C+Pieter+W&rft.au=Sijpkens%2C+Meertien+K&rft.au=Meijers%2C+Joost+C&rft.date=2011-10-04&rft.issn=1524-4539&rft.eissn=1524-4539&rft.volume=124&rft.issue=14&rft.spage=1573&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.111.029017&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1524-4539&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1524-4539&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1524-4539&client=summon